Open in app
Sign inGet started
It’s time to talk about Parkinson’s dementia

It’s time to talk about Parkinson’s dementia

Problems with memory and thinking are common in Parkinson’s. But people with the condition and professionals find it hard to talk about.
Go to the profile of Claire Bale
Claire Bale
Highlights from the World Parkinson Congress — Emerging therapies

Highlights from the World Parkinson Congress — Emerging therapies

Summary of new and emerging therapies from the World Parkinson Congress
Go to the profile of Dr Becky Jones
Dr Becky Jones
Stories to tell — South Asian Heritage Month

Stories to tell — South Asian Heritage Month

Celebrating South Asian heritage month with Shafaq’s story from our latest Race Equality in Research event in Bradford.
Go to the profile of Naveena Kapur
Naveena Kapur
Highlights from the World Parkinson Congress — Hot Topics

Highlights from the World Parkinson Congress — Hot Topics

Updates on some of the most exciting Parkinson’s research going on across the world, and presented at the World Parkinson Congress 2023.
Go to the profile of Dr Becky Jones
Dr Becky Jones
Sign up to our Research Support Network (RSN) to get the latest news and opportunities directly to your email.
Sign up for free
NLX-112 trial results — behind the headlines

NLX-112 trial results — behind the headlines

Results offer hope that a new drug called NLX-112 could provide a valuable new treatment option for Parkinson’s within years not decades.
Go to the profile of Claire Bale
Claire Bale
Taking part in research — my perspective

Taking part in research — my perspective

Ron Bernstein shares his experience of being part of a Parkinson’s research study.
Go to the profile of Dr Becky Jones
Dr Becky Jones
Improving our understanding of Parkinson’s symptoms to develop potential treatments

Improving our understanding of Parkinson’s symptoms to develop potential treatments

Co-authored by Claire E. O’Hanlon, Carrie M. Farmer, Catherine Kopil, Yuge Xiao, Angelica Asis, and Naveena Kapur.
Go to the profile of Naveena Kapur
Naveena Kapur
Engaging the Parkinson’s Community at our Race Equality in Research events

Engaging the Parkinson’s Community at our Race Equality in Research events

Find out how we’ve been working with the Race Equality in Research Steering Group to develop community information events.
Go to the profile of Dr Becky Jones
Dr Becky Jones
Brain Awareness Week — studying the power of the brain’s self-cleaning system

Brain Awareness Week — studying the power of the brain’s self-cleaning system

We celebrate Brain Awareness Week by catching up with Parkinson’s UK funded researcher Dr Ian Harrison.
Go to the profile of Dr Becky Jones
Dr Becky Jones
Understanding alpha-synuclein— nearly 30 years of research with Professor Maria Grazia Spillantini

Understanding alpha-synuclein— nearly 30 years of research with Professor Maria Grazia Spillantini

The pioneering research into the role of alpha-synuclein and what it means for the future of potential treatments for Parkinson’s.
Go to the profile of Naveena Kapur
Naveena Kapur
Developing an app to record and help prevent falls

Developing an app to record and help prevent falls

Falls affect around 60% of people with Parkinson’s every year. We met Rosie, Elaine & Gerry to hear how they are addressing this problem.
Go to the profile of Dr Becky Jones
Dr Becky Jones
2022 research moments

2022 research moments

2022 has been a year of unity and people powering research. We reflect on progress and thank the people who have made it happen.
Go to the profile of Naveena Kapur
Naveena Kapur
Diagnosing Parkinson’s earlier — so what?

Diagnosing Parkinson’s earlier — so what?

This blog helps explain why diagnosing Parkinson’s earlier would benefit research and people affected by Parkinson’s.
Go to the profile of Dr Katherine Fletcher
Dr Katherine Fletcher
Following the path to a new drug, together

Following the path to a new drug, together

£16m funding announced to drive forward a drug that could slow the loss of brain cells in Parkinson’s .
Go to the profile of Dr Katherine Fletcher
Dr Katherine Fletcher
Sharks, Parkinson’s and dementia: what’s the link?

Sharks, Parkinson’s and dementia: what’s the link?

Hidden away in some of the oldest creatures on earth lives a naturally occurring compound that may be key to tackling Parkinson’s dementia.
Go to the profile of Dr Becky Jones
Dr Becky Jones
Finding partners — the future of GDNF

Finding partners — the future of GDNF

We still believe that GDNF has real promise. The next step is to find funding partners to get even closer to a possible future trial.
Go to the profile of Dr Katherine Fletcher
Dr Katherine Fletcher
Taking part in research — you’re in control

Taking part in research — you’re in control

We cover what is involved in taking part in research, how you can find opportunities and answer some of the most frequently asked…
Go to the profile of Dr Becky Jones
Dr Becky Jones
What’s going on with research into Parkinson’s?

What’s going on with research into Parkinson’s?

We chat to Dr Kevin McFarthing who helps to summarise all of the active research into Parkinson’s in a way that everyone can understand.
Go to the profile of Dr Katherine Fletcher
Dr Katherine Fletcher
Increasing diversity in research: Ask the Expert

Increasing diversity in research: Ask the Expert

Much of what we understand about Parkinson’s has come from studies of affluent white populations. We speak to experts trying to change…
Go to the profile of Dr Becky Jones
Dr Becky Jones
From a sleep disorder to movement disorder, a new approach to stopping Parkinson’s

From a sleep disorder to movement disorder, a new approach to stopping Parkinson’s

Parkinson’s is the fastest growing neurological condition in the world — there is no cure, and no treatment that slows its progression. In…
Go to the profile of Dr Beckie Port
Dr Beckie Port
What’s the Parkinson’s Virtual Biotech?

What’s the Parkinson’s Virtual Biotech?

This blog gives a snapshot of the research projects we’re funding through the Parkinson’s Virtual Biotech to deliver new treatments.
Go to the profile of Dr Katherine Fletcher
Dr Katherine Fletcher
Investigating treatments to improve mood and slow the progression of Parkinson’s

Investigating treatments to improve mood and slow the progression of Parkinson’s

Researchers are looking for 408 people with Parkinson’s to help find a treatment to improve mood and potentially slow Parkinson’s.
Go to the profile of Dr Katherine Fletcher
Dr Katherine Fletcher
Driving forward race equality in research

Driving forward race equality in research

With help from our steering group, we have outlined priorities and actions to take important steps towards race equality in research.
Go to the profile of Dr Becky Jones
Dr Becky Jones
A different lunchtime for 4D pharma- sharing experience of Parkinson’s

A different lunchtime for 4D pharma- sharing experience of Parkinson’s

4D pharma, a UK based biotechnology company, is working with a patient advisory board to shape an upcoming trial. Find out more …
Go to the profile of Dr Laura Jacobs
Dr Laura Jacobs
A new clinical trial of GDNF — an update

A new clinical trial of GDNF — an update

In February 2021, we announced our bold plans to invest in driving forward research into the experimental Parkinson’s treatment, GDNF. We…
Go to the profile of Dr Beckie Port
Dr Beckie Port
Women and Parkinson’s

Women and Parkinson’s

What are the unmet needs for women living with Parkinson’s? What we know so far …
Go to the profile of Dr Katherine Fletcher
Dr Katherine Fletcher
Supplements and Parkinson’s

Supplements and Parkinson’s

This blog explains the research evidence behind some of the most asked about supplements and Parkinson’s.
Go to the profile of Dr Katherine Fletcher
Dr Katherine Fletcher
Taking steps towards race equality in Parkinson’s research

Taking steps towards race equality in Parkinson’s research

Up to 1 in 20 people with Parkinson’s in the UK may be of Black, Asian or mixed heritage but research struggles to involve these communities
Go to the profile of Claire Bale
Claire Bale
About Parkinson’s UKLatest StoriesArchiveAbout MediumTermsPrivacyTeams